Vaccine is a peer-reviewed medical journal, published by Elsevier. It is targeted towards medical professionals who are interested in vaccines and vaccination. It describes itself as "an interface between academics, those in research and development, and workers in the field. Relevant topics range from basic research through to applications, safety and legislation."
A breakthrough in the search for safe immunization against dengue fever has emerged after trials at A*STAR showed a new vaccine without live viruses induces an effective immune response.
Sep 11, 2015
0
15
A team of scientists at Royal Holloway, led by Professor George Dickson, and as part of the UK HIV Vaccine Consortium, led by Professor Jonathon Weber at Imperial College London, has developed a prototype HIV vaccine vector ...
Nov 16, 2015
0
201
As countries struggle to contain the COVID-19 pandemic, vaccination uptake is a public health priority now more than ever. Efforts to increase vaccinations vary greatly around the globe. A new McGill-led study comparing policies ...
Oct 21, 2020
0
3
Vaccines that protect against severe illness, death and lingering long COVID symptoms from a coronavirus infection were linked to small increases in neurological, blood, and heart-related conditions in the largest global ...
Feb 19, 2024
0
29
A new 23-country study by a multidisciplinary team of researchers in the journal Vaccine sheds light on the factors that contribute to COVID-19 vaccine hesitancy among health care providers.
May 31, 2022
0
23
Unreliable yearly flu jabs could be a thing of the past as researchers close in on technology that will take down the deadly virus once and for all.
Jun 20, 2017
0
209
Immediately after COVID-19 vaccination, Danes experienced side effects such as malaise, fever and fatigue. Serious side effects such as facial paralysis and allergic reactions are rare, but 30% of menstruating women reported ...
Aug 29, 2023
0
40
Each year, more than 100 million newborns around the world receive vaccinations against Mycobacterium tuberculosis, or TB, which infects about one-quarter of the world's population. Facilities across the world produce several ...
Jan 28, 2020
0
1
New engineered spider protein could be the start of a new generation of anti-venom vaccines, potentially saving thousands of lives worldwide. The new protein, created from parts of a toxin from the reaper spider, is described ...
May 9, 2013
0
0
Whooping cough bacteria are becoming smarter at colonizing and feeding off unwitting hosts, strengthening calls for a new vaccine, according to UNSW researchers.
Jan 16, 2020
0
475
